United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership10,292 shares
Latest Disclosed Value $ 3,281,604
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.49% increase in ownership of UTHR / United Therapeutics Corporation

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 10,292 shares of United Therapeutics Corporation (US:UTHR) valued at $3,281,604 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 10,242 shares of United Therapeutics Corporation. This represents a change in shares of 0.49% during the quarter. The current value of the position is $5,659,262 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,292 50 0.49 3,282 0.12 0.0434
2025-04-25 2025-02-28 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,242 12 0.12 3,278 -13.54 0.0442
2025-01-27 2024-11-30 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,230 70 0.69 3,790 2.63 0.0514
2024-10-29 2024-08-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,160 -621 -5.76 3,694 24.51 0.0547
2024-07-26 2024-05-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,781 125 1.17 2,966 23.38 0.0470
2024-04-24 2024-02-29 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,656 155 1.48 2,404 -4.60 0.0401
2024-01-24 2023-11-30 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,501 15 0.14 2,520 7.14 0.0483
2023-10-27 2023-08-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,486 150 1.45 2,353 8.54 0.0460
2023-07-26 2023-05-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,336 30 0.29 2,168 -14.52 0.0468
2023-04-27 2023-02-28 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,306 225 2.23 2,536 -10.14 0.0620
2023-01-26 2022-11-30 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 10,081 235 2.39 2,822 26.45 0.0705
2022-10-26 2022-08-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 9,846 335 3.52 2,231 1.87 0.0558
2022-07-29 2022-05-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 9,511 260 2.81 2,191 42.49 0.0558
2022-04-28 2022-02-28 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 9,251 -620 -6.28 1,538 -17.81 0.0356
2022-01-25 2021-11-30 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 9,871 258 2.68 1,871 -9.44 0.0391
2021-10-26 2021-08-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 9,613 198 2.10 2,066 18.00 0.0453
2021-07-22 2021-05-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 9,415 36 0.38 1,750 11.68 0.0435
2021-04-23 2021-02-28 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 9,379 540 6.11 1,568 33.70 0.0408
2021-01-20 2020-11-30 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 8,839 -12 -0.14 1,172 23.89 0.0350
2020-10-16 2020-08-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 8,851 283 3.30 947 -6.34 0.0292
2020-07-20 2020-05-31 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 8,568 1,867 27.86 1,011 46.59 0.0395
2020-04-24 2020-02-29 NP UNITED THERAPEUTICS CORP DEL EC US91307C1027 6,701 6,701 690 0.0308
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.